Cargando…
Resistance Patterns Associated with HCV NS5A Inhibitors Provide Limited Insight into Drug Binding
Direct-acting antivirals (DAAs) have significantly improved the treatment of infection with the hepatitis C virus. A promising class of novel antiviral agents targets the HCV NS5A protein. The high potency and broad genotypic coverage are favorable properties. NS5A inhibitors are currently assessed...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246218/ https://www.ncbi.nlm.nih.gov/pubmed/25384189 http://dx.doi.org/10.3390/v6114227 |